ORAGENICS, INC. Property, Plant and Equipment, Gross
ORAGENICS, INC. (OGEN) had Property, Plant and Equipment, Gross of $1.48 million as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2024-03-29
- 2023-06-30: Property, Plant and Equipment, Gross $1.48M.
- 2023-03-31: Property, Plant and Equipment, Gross $1.48M.
- 2022-12-31: Property, Plant and Equipment, Gross $1.48M.
- 2021-12-31: Property, Plant and Equipment, Gross $1.67M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2023-06-30 | $1.48M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.48M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.48M 10-K · filed 2024-03-29 |
| 2021-12-31 | $1.67M 10-K · filed 2023-04-17 |
| 2020-12-31 | $1.76M 10-K/A · filed 2022-07-29 |
| 2019-12-31 | $1.76M 10-K · filed 2021-03-01 |
| 2018-12-31 | $1.73M 10-K · filed 2020-03-04 |
| 2017-12-31 | $1.61M 10-K · filed 2019-03-29 |
| 2016-12-31 | $1.61M 10-K · filed 2018-02-16 |
| 2015-12-31 | $1.59M 10-K · filed 2017-02-27 |
| 2014-12-31 | $1.67M 10-K · filed 2016-03-30 |
| 2013-12-31 | $1.56M 10-K · filed 2015-02-27 |
| 2012-12-31 | $1.54M 10-K · filed 2014-02-28 |
| 2011-12-31 | $1.53M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |